CME Group Inc. CME

Key data

The business

CME Group owns the largest futures and options marketplace on earth, and it owns the whole vertical: it lists the contract, matches the order, and clears it through its own clearing house. The products are the plumbing of finance: SOFR and Treasury futures for interest rates, E-mini S&P for equities, WTI for oil, plus agriculture, metals and currencies. Money comes from three places: fees on each contract (rate per contract times average daily volume), market-data subscriptions sold to anyone who needs the prices, and smaller access and collateral fees. The moat is liquidity and cleared open interest. A hedger goes where the depth already is, and once a position sits in CME's clearing house, netted against every other position there, moving it somewhere else means posting more collateral for less efficiency. Liquidity begets liquidity, and the margin savings lock it in place. That is why no serious challenger has pried loose CME's rate complex in decades.

The numbers

Two things carry this business: how much gets hedged, and how little it costs CME to run the machine. Start with the recent quarters.

Q1 2026 was the tell: revenue jumped 14.5% from a year earlier as tariff and rate uncertainty sent everyone rushing to hedge. Q2 gave most of the excitement back. The soft second quarter that stood out at the start of this month held rather than broke: revenue grew just 0.8% from the prior year, confirming the spring's record volume was volatility, not a run rate stepping permanently higher. On the Street's adjusted line CME still cleared the bar every quarter, most recently $2.99 against $2.91 expected.

The long arc is the reason to own it. Over five years revenue compounded 8.6% and net income 11.5%, with net margin widening from 56% to 62% because the cost base barely moves as volume rises.

Through the first half of 2026 diluted EPS is $6.06, up 11.6% on the same half last year. The whole edifice runs on almost nothing: capital spending is about $84M against $6.5B of revenue, so nearly every extra dollar of fees drops through. What I believe the market does not: the post-ZIRP rate complex has a structurally higher floor of hedging demand, and the print that settles it is rate-contract volume holding up in a quarter when realized volatility is falling.

Management

Terry Duffy has run this for two decades and knows exactly what it is. Capital allocation is the signature: instead of steady buybacks, CME pays a large regular dividend plus a variable annual dividend that sweeps out excess cash, which is honest for a business whose earnings swing with volatility. Returns on capital are healthy for a company this asset-light, 15.5% on equity, and the balance sheet is a fortress at 0.24x net debt to EBITDA. Insiders have been net sellers over the past year, $27.0M sold against $661K bought, and every large sale is Duffy: $7.75M in May 2026, two more totaling $6.7M last December. Plan status is not disclosed in the filings I can see, so read them as ordinary diversification by a long-tenured insider rather than a signal, but note the direction.

How it fails or surprises you

Volume mean-reversion. Q2's 0.8% revenue growth, right after Q1's 14.5%, is the fact my structural read explains least well. Roughly four-fifths of revenue rides average daily volume. If volatility keeps fading toward 2025's calm, transaction fees fall with it and 2026 prints as a peak. Watch rate-complex daily volume against the 2025 baseline over the next two quarters.

Open-interest fragmentation. FMX, the bank-backed rate-futures venue, is aiming directly at SOFR and Treasury futures, the one place a rival could crack the moat. It has not moved sustained open interest yet, and CME's cross-margining is the reason. Watch for any durable migration of SOFR open interest, the only metric that would prove the switching cost broke.

Structural rate demand plus repricing (right tail). If higher-for-longer entrenches hedging, market-data prices keep climbing, and newer products (event and crypto contracts) scale, volume steps up permanently. The market prices this as cyclical at 24 times earnings, below CME's decade norm. The reveal is rate volume holding through a genuinely low-volatility quarter.

Closing thoughts

The market knows CME is the toll road. The question is whether this year's volume is permanent or temporary, and the next two quarters will tell you: if rate-contract volume holds through a calm stretch, the structural case lands; if it fades back toward 2025, the cyclical read wins. The tail is modestly fatter to the right. Earnings compound low-teens, the multiple sits below its own ten-year range, and the balance sheet cannot break. If volume does mean-revert, the damage is a mid-single-digit revenue give-back and a flat year, not a permanent loss; if the rate regime holds, both earnings and the multiple re-rate together. The left tail, a rival clearing house splitting open interest, is real but has stayed theoretical for decades because netting is that sticky.

The bet is still that the world keeps needing one place to bet on where interest rates go, and that place stays CME. It breaks if rate-contract daily volume rolls back toward 2025 levels while the multiple holds. The one pair that tells you first: quarterly rate volume and market-data revenue, read together each quarter.